Xeris Biopharma(XERS) - 2024 Q4 - Earnings Call Transcript

Xeris Biopharma Holdings (XERS) Q4 2024 Earnings Call March 06, 2025 04:35 PM ET Company Participants Allison Wey - Senior Vice President of Investor Relations & Corporate CommunicationsJohn Shannon - CEOSteve Pieper - Chief Financial OfficerGlen Santangelo - Managing DirectorMazahir Alimohamed - Biotech Equity Research Associate Conference Call Participants Chase Knickerbocker - Senior Equity Research Analyst - HealthcareOren Livnat - MD - Senior Healthcare AnalystDavid Amsellem - Sr. Research AnalystLelan ...